Board of Directors
The Board of Directors oversees the day-to-day running of our association and the Chairman of the Board is the highest representative of Asebio. The assembly held in December 2019 chose the candidacy with Ana Polanco (Merck) as chairwoman and Belén Barreiro (Ingenasa), Elena Rivas (A4Cell) y Javier Terriente (Zeclinics) as the three vice presidents. They will hold these offices until late 2021.
Ana Polanco - Presidenta de AseBio
Director of Market Access and Corporate Affairs at Merck since 2015. She is also a member of FEI (Forum of Innovative Companies), of the Board of Directors of the Digital Health Association and Dr. of the Executive Committee of CLOSINGAP.
CEO at Arrays for Cell Nanodevices, SL
General Director at 3P Biopharmaceuticals since 2007, Dámaso Molero has a long experience in pharmaceutical production, with more than 10 years as a plant manager in Shionogi
CEO and Vice President of Business Development and Licensing at Ability Pharma since 2009. At the same time, he has been a consultant for biotech projects of the investment company Kieretsu Forum Spain.
Executive Chairman of the Board at Atrys Health. Torres, a physician specializing in Clinical Pharmacology, is also part of the board of various organizations with social purposes.
Director of Agricultural Policies and Institutional Relations at Bayer Crop Science Iberia, the agro division of the multinational, which is the third largest company in the world in products for agriculture.
Co-founder and president since 2001 of the investment company Cross Road Biotech, Castellón was Secretary of State for Health and Consumer Affairs (1996-2000), a position from which he promoted multiple projects of great relevance to the sector.
CEO at Science & Innovation Link Office (SILO)
Founding partner and CEO at Vivia Biotech, a company specializing in drug screening, which he joined after 10 years working as a lawyer in the United States.